TPMT and colitis: A daily AZA dose of 2–3 mg/kg for individuals with wild-type TPMT is recommended by the Clinical Pharmacogenetics Implementation Consortium guidelines [39], and 1.5 to 2.5 mg∙kg-1∙d-1 is recommended by the European Crohn’s and Colitis Organization [40].